Revision history of "GlioMAB — Integrative Technology Platform for the Identification and Therapeutic Evaluation of Nanobodies" (Q3677950)

22 March 2024

• curprev 15:0815:08, 22 March 2024‎ DG Regio talk contribs‎ 66,974 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.3553968056049749

12 January 2024

• curprev 10:0110:01, 12 January 2024‎ DG Regio talk contribs‎ 66,686 bytes +365‎ ‎Changed an Item

19 June 2023

• curprev 12:1512:15, 19 June 2023‎ Admin talk contribs‎ 66,321 bytes 0‎ BatchIngestion

10 June 2023

• curprev 07:5207:52, 10 June 2023‎ Admin talk contribs‎ 66,321 bytes +437‎ BatchIngestion

8 June 2023

• curprev 07:4807:48, 8 June 2023‎ DG Regio talk contribs‎ 65,884 bytes +2,166‎ ‎Changed an Item

11 August 2022

• curprev 14:5414:54, 11 August 2022‎ DG Regio talk contribs‎ 63,718 bytes +44,213‎ ‎Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

14 January 2022

• curprev 00:3700:37, 14 January 2022‎ DG Regio talk contribs‎ 19,505 bytes +2,270‎ ‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations

13 January 2022

• curprev 07:2607:26, 13 January 2022‎ DG Regio talk contribs‎ 17,235 bytes +2,223‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

6 December 2021

• curprev 12:5312:53, 6 December 2021‎ DG Regio talk contribs‎ 15,012 bytes +2,253‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

1 December 2021

• curprev 07:4107:41, 1 December 2021‎ DG Regio talk contribs‎ 12,759 bytes +2,229‎ ‎Created claim: summary (P836): Die Entwicklung neuer Arzneimittel gegen Krebs, einschließlich Bioarzneimitteln, ist derzeit ein langwieriger und kostspieliger Prozess, der hauptsächlich auf folgende Gründe zurückzuführen ist: Von der Schwierigkeit, selektive Moleküle zu identifizieren und die Bedingungen für das Screening von Kandidatenmolekülen zu optimieren, -In-vitro-In-vitro-Zellmodelle nicht ordnungsgemäß reproduzierte intratumorale Bedingungen, die dazu führen, dass be...

27 November 2021

• curprev 12:3412:34, 27 November 2021‎ DG Regio talk contribs‎ 10,530 bytes −2,202‎ ‎Removed claim: summary (P836): Le développement de nouveaux agenten anticancéreux, y compris les Biomédicaments, est actuellement un processus long et coûteux, en grande partie en raison: —De La difficulté à identifier des Molécules sélectives et à Optimizer les conditions de criblage de Molécules Kandidaten, -Des conditions intratumorales non reproduites correctement sur les modèles cellulaires in vitro conduisant à l‚échec de certains candidats médicaments à donner les r...

26 November 2021

• curprev 23:0423:04, 26 November 2021‎ DG Regio talk contribs‎ 12,732 bytes +2,202‎ ‎Created claim: summary (P836): Le développement de nouveaux agenten anticancéreux, y compris les Biomédicaments, est actuellement un processus long et coûteux, en grande partie en raison: —De La difficulté à identifier des Molécules sélectives et à Optimizer les conditions de criblage de Molécules Kandidaten, -Des conditions intratumorales non reproduites correctement sur les modèles cellulaires in vitro conduisant à l‚échec de certains candidats médicaments à donner les rés...
• curprev 14:3814:38, 26 November 2021‎ DG Regio talk contribs‎ 10,530 bytes +169‎ ‎Changed label, description and/or aliases in de: translated_label

24 November 2021

• curprev 15:2415:24, 24 November 2021‎ DG Regio talk contribs‎ 10,361 bytes +431‎ ‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string

18 November 2021

• curprev 16:3116:31, 18 November 2021‎ DG Regio talk contribs‎ 9,930 bytes +167‎ ‎Changed label, description and/or aliases in en: translated_label
• curprev 16:3116:31, 18 November 2021‎ DG Regio talk contribs‎ 9,763 bytes +1,981‎ ‎Created claim: summary (P836): The development of new anticancer agents, including bio-drugs, is currently a long and costly process, largely due to: —The difficulty in identifying selective molecules and optimising the screening conditions of candidate molecules, -Intratumoral conditions not correctly reproduced on in vitro cell models leading to the failure of certain drug candidates to give the expected results in vivo, while they showed promising activities in the initia...

17 November 2021

• curprev 14:3914:39, 17 November 2021‎ DG Regio talk contribs‎ 7,782 bytes +7,017‎ ‎Changed an Item: importing one item from France
• curprev 14:3914:39, 17 November 2021‎ DG Regio talk contribs‎ 765 bytes −7,017‎ ‎Removed claims Tag: Replaced
• curprev 12:0312:03, 17 November 2021‎ DG Regio talk contribs‎ 7,782 bytes +4‎ ‎Changed label, description and/or aliases in en: Setting new description
• curprev 12:0312:03, 17 November 2021‎ DG Regio talk contribs‎ 7,778 bytes +7,778‎ ‎Created a new Item: importing one item from France